Green Park & Golf Ventures — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Barricade Therapeuticsbarricadetherapeutics.com in 𝕏May 2026

Barricade Therapeutics is a biotech company focused on oncology drug development, working to advance cancer treatments through evidence-based clinical pharmacology.

BiotechHealthtechFort Worth, US

Neil C. Thapar(Co-Founder, Board Chairman, CEO & Chief Scientific Officer)inJohn Walling(Co-Founder, SVP, CMC)inMariam E. Morris(Chief Operating Officer)Scott Jordan(Chief Financial Officer)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.